Literature DB >> 1106937

Clinical biostatistics. XXXV. The persistent clinical failures and fallacies of the UGDP study.

A R Feinstein.   

Abstract

Mesh：

Substances：

Year:  1976        PMID： 1106937     DOI： 10.1002/cpt197619178

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  6 in total

1.  Jerome Cornfield's Bayesian approach to assessing interim results in clinical trials.

Authors:  James J Schlesselman
Journal:  J R Soc Med       Date:  2016-01       Impact factor: 5.344

Review 2.  The use of sulphonylureas in the elderly.

Authors:  M B Graal; B H Wolffenbuttel
Journal:  Drugs Aging       Date:  1999-12       Impact factor: 3.923

3.  The crux of the UGDP. Spurious results and biologically inappropriate data analysis.

Authors:  C Kilo; J P Miller; J R Williamson
Journal:  Diabetologia       Date:  1980-03       Impact factor: 10.122

Review 4.  Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).

Authors:  B H Wolffenbuttel; T W van Haeften
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

Review 5.  Adverse cardiovascular effects of sulphonylurea drugs. Clinical significance.

Authors:  R Huupponen
Journal:  Med Toxicol       Date:  1987 May-Jun

6.  Effect of intravenous infusion of insulin in diabetics with acute myocardial infarction.

Authors:  R S Clark; M English; G P McNeill; R W Newton
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.